Overview

RESTORE: buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

Status:
Not yet recruiting

Trial end date:
2025-04-30

Target enrollment:

Participant gender:

Summary

RESTORE is a randomized clinical trial investigating the safety and feasibility of using EEG treatment targets (burst suppression vs. seizure suppression) for post-cardiac arrest refractory status epilepticus treatment.

Phase:

Phase 2

Details

Lead Sponsor:

University of California, San Francisco

Collaborator:

The ZOLL Foundation

Treatments:

Anesthetics